drugs
|
specialties
|
education
|
general news
|
points
UnregisterUser
Singapore
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Others Services
Singapore
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
drugs
|
specialties
|
education
|
general news
|
points
UnregisterUser
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Products
About
×
Distributed by
Zuellig Pharma
Apply
Distributed by
Zuellig Pharma
Apply
AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD
Filter
Featured products of
Amgen
Show All
Show All
Amgevita
Blincyto
Kyprolis
Neulastim
Neupogen
Parsabiv
Prolia
Repatha
Vectibix
Xgeva
Amgevita
Amgevita soln for inj (pre-filled autoinjector) 40 mg/0.8 mL
adalimumab
Packing/Price
2's, 4's, 6's, 1's
MIMS Class
Immunosuppressants, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Amgevita soln for inj (pre-filled syringe) 20 mg/0.4 mL
adalimumab
Packing/Price
1's
MIMS Class
Immunosuppressants, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Amgevita soln for inj (pre-filled syringe) 40 mg/0.8 mL
adalimumab
Packing/Price
6's, 1's, 2's, 4's
MIMS Class
Immunosuppressants, Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Blincyto
Blincyto powd for infusion 35 mcg
blinatumomab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC19 - blinatumomab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Kyprolis
Kyprolis powd for infusion 60 mg
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XX45 - carfilzomib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
Neulastim
Neulastim soln for inj 6 mg/0.6 mL
pegfilgrastim
Packing/Price
0.6 mL x 1's
MIMS Class
Supportive Care Therapy, Haematopoietic Agents
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen soln for inj 30 Million unit/0.5 mL
filgrastim
Packing/Price
0.5 mL x 1's
MIMS Class
Supportive Care Therapy, Haematopoietic Agents
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Parsabiv
Parsabiv soln for inj 2.5 mg/0.5 mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Parsabiv soln for inj 5 mg/mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
(autoinjector) 1's, 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix soln for infusion 100 mg/5 mL
panitumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC08 - panitumumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Xgeva
Xgeva soln for inj 120 mg/1.7 mL
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Distributed by
Zuellig Pharma
Show All
Show All
Amgevita
Blincyto
Kyprolis
Neulastim
Neupogen
Parsabiv
Prolia
Repatha
Vectibix
Xgeva
Amgevita
Amgevita soln for inj (pre-filled autoinjector) 40 mg/0.8 mL
adalimumab
Packing/Price
1's, 2's, 4's, 6's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Amgevita soln for inj (pre-filled syringe) 20 mg/0.4 mL
adalimumab
Packing/Price
1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Amgevita soln for inj (pre-filled syringe) 40 mg/0.8 mL
adalimumab
Packing/Price
1's, 2's, 4's, 6's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Blincyto
Blincyto powd for infusion 35 mcg
blinatumomab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC19 - blinatumomab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Kyprolis
Kyprolis powd for infusion 60 mg
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XX45 - carfilzomib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
Neulastim
Neulastim soln for inj 6 mg/0.6 mL
pegfilgrastim
Packing/Price
0.6 mL x 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen soln for inj 30 Million unit/0.5 mL
filgrastim
Packing/Price
0.5 mL x 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Parsabiv
Parsabiv soln for inj 2.5 mg/0.5 mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Parsabiv soln for inj 5 mg/mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
(autoinjector) 1's, 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix soln for infusion 100 mg/5 mL
panitumumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC08 - panitumumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Xgeva
Xgeva soln for inj 120 mg/1.7 mL
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member?
Sign in